Back

ResearchAndMarkets.com adds global palmoplantar pustulosis market report through 2035

Verifying
  • ResearchAndMarkets.com added a report covering the global palmoplantar pustulosis market through 2035.
  • 2025-2035 analysis covers treatment types, distribution channels and North America, Europe, Asia-Pacific and other regions.
  • Japan and South Korea approved guselkumab and risankizumab biologics for palmoplantar pustulosis treatment.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.